Autoimmune disorders are among the most prevalent chronic diseases across the globe. Emerging treatments for autoimmune disorders focus on “adoptive cell therapies,” or those using cells from a patient’s own body to achieve immunosuppression. These therapeutic cells are recognized by the patient’s body as “self,” therefore limiting side effects, and are specifically engineered to localize the intended therapeutic effect.
Click here for original story, Lipid nanoparticles that deliver mRNA to T cells hold promise against autoimmune diseases
Source: Phys.org